Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Patent
1995-06-05
1996-07-23
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
424549, 424582, 424577, 424557, 424937, 800 2, 800DIG5, A61K 4900
Patent
active
055387136
ABSTRACT:
Primordial tissue is introduced into immunodeficient hosts, where the primordial tissue develops and differentiates. The chimeric host allows for investigation of the processes and development of the xenogeneic tissue, testing for the effects of various agents on the growth and differentiation of the tissue, as well as identification of agents involved with the growth and differentiation.
REFERENCES:
Groseworth et al., Anat. Embryol. 165:291-302 (1982).
Usadel et al., The Lancet, Feb. 12, 1977, p. 365.
Bastert et al., Endo. 101(2):365-368 (1977).
H. Fiebig, et al. (1987) Eur. J. Clin. Oncol. 23:937-948. Colony assay with human tumor xenografts, murine tumors and human bone marrow.
R. Taetle, et al. (1986) Cancer 58:1969-1978. Use of nude mouse xenografts as preclinical drug screens.
A. Drugan et al. (1989) Am. J. Obstet. Gyn. 160:289-293. Fetal organ and xenograft transplantation.
I. Moll, et al. (1990) J. Invest. Derm. 94:359-364. Intraepidermal formation of Merkel cells in xenografts of human fetal skin.
K. Elias, et al. (1990) Tranplant. Proc. 22:806-807. Development of human fetal xenograft transplants in diabetic nude mice.
R. Namikawa, et al. (1990) J. Exp. Med. 172:1055-1063. Long-term human hematopoiesis in the SCID-hu mouse.
H. Winter, et al. (1991) Gastroenterology 100:89-98. Human intestine matures as nude mouse xenograft.
D. Mosier (1991) Adv. Immunol. 50:303-325. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS.
J. Fleischmann, et al. (1985) J. Urol. 134:570-574. Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities.
J. Bennet, et al. (1986) J. Surg. Oncol. 33:8-13. Accurate prediction of experimental canver chemosensitivity using the subrenal capsule xenograft assay.
McCune et al., Science 241:1632-1639 (1988).
Poulsen et al., Nature 248:247-249 (1974).
Bosma et al., Nature 301:527-530 (1983).
Fulop et al., J. Immunology 136(12):4438-4443 (1986).
Chambers Jasemine C.
Rowland Bertram I.
Sherwood Pamela J.
Systemix, Inc.
LandOfFree
Primordial implants in immunodeficient hosts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Primordial implants in immunodeficient hosts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Primordial implants in immunodeficient hosts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-711236